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state conditions. There are different types of stem 
cells; i) most primitive totipotent SC — the zygote 
that is able to produce the embryo and placenta, ii) 
pluripotent SC — embryonic stem cells that give 
rise only to the embryo, iii) multipotent SC — stem 
cells that give rise to three germ layers, and iv) tis-
sue commied stem cells (TCSC) that give rise to 
cells building particular tissues (Lemoli et al., 2005). 
Until recently only few tissues were recog-
nized to contain stem cells. But this perspective has 
changed due to intensive research into this subject. 
We know now that probably all tissues contain 
a population of SC that are responsible for their 
growth and regeneration. Numerous organs have 
been shown to contain specific stem cells: brain tis-
sue — neuronal stem cells (Eriksson et al., 1998; Jo-
hansson et al., 1999), liver tissue — oval stem cells 
(Alison et al., 1996; 2004) or heart tissue — cardi-
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neuronal-, hepatic- or skeletal muscle-stem cells. By employing these markers several laboratories 
are trying to isolate stem cells for potential clinical use. New characteristics of stem cells such as 
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Stem cells biology is one of the venues of to-
day biomedical research. It is a very promising field 
with a lot of potential to generate new therapies. 
Especially in the last decade several important dis-
coveries have been made that shed new light onto 
the biology of stem cells. But at the same time this 
new knowledge has raised a lot of new questions 
and controversies. 
Stem cells are very rare cells with two major 
features; self-renewal and an ability to differentiate 
into mature cells (Weissman, 2000). Self-renewal is 
a process during which a stem cell can divide sym-
metrically and give rise to two daughter stem cells 
or divide asymmetrically and give rise to one stem 
cell and one more mature cell. In the first scenario 
the number of SC is increased, an important feature 
for stem cells regeneration.  In the second scenario 
SC number is maintained as it happens in steady 
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ac stem cells (Beltrami et al., 2003; Laugwitz et al., 
2005), to mentioned just a few examples. The best 
studied are hematopoietic stem cells (HSC) that give 
rise to all blood cell lineages, both of myeloid and 
lymphoid origin.
In this review we would like to summarize 
recent advances made in stem cell biology, particu-
larly in the ability to expand them, the new ways to 
isolate stem cells and also to discuss some contro-
versies about stem cell behavior and features.
NUMBER IS THE PROBLEM
Stem cells from the different tissues present 
great potential in cellular therapies and in our quest 
for longevity. Unfortunately, in most of the tissues, 
there are not enough of them to fulfill these expecta-
tions. HSC are the best known stem cells and they 
are already used routinely in hematology and trans-
plantation (Kondo et al., 2003). We collect them from 
different sources such as bone marrow, peripheral 
blood and cord blood (Kondo et al., 2003; Ballen, 
2005). Despite these multiple sources quite oen we 
cannot obtain a sufficient number of HSC for treat-
ment, especially when cord blood is used (Ballen, 
2005). Because of that since their discoveries there 
has been a growing number of different approaches 
to increasing their number in vitro. Cytokines that 
are present in the bone marrow and stimulate pro-
liferation of hematopoietic cells were first used in at-
tempts to increase the number of HSC in cultures. 
The goal was that they would induce proliferation 
but not differentiation of stem cells (Luskey et al., 
1992; Bryder & Jacobsen, 2000). Unfortunately, they 
did not really succeed and aer the early enthusi-
asm for some of the studies, generally they were 
non-reproducible or the increase was only few-fold.
Bone marrow consists of different cell types, 
the extracellular matrix (ECM) and soluble factors, 
mainly cytokines and growth factors (Moore, 2004). 
Non-hematopoietic cells present in the bone mar-
row include stromal cells, endothelial cells and os-
teoblasts that together with ECM form so called 
“niches” where stem cells reside. Because bone mar-
row supports hematopoietic cell proliferation and 
differentiation in the steady state, it seems logical 
that cells present in the bone marrow should also 
support the growth of stem cells. This observation 
has led to the establishment of feeder layer cells de-
rived from bone marrow stromal cells. These cells 
are able to promote proliferation and differentiation 
of HSC in long-term cultures (Dexter et al., 1977; 
Sutherland et al., 1989). Recently, in order to further 
increase the SC-promoting potential of feeder layer 
cells, genetic modification has been introduced. One 
of the approaches is based on introduction of genes 
that inhibit differentiation of target cells. The Notch 
pathway, which controls different cellular processes 
including proliferation, differentiation or apotosis, is 
also responsible for maintaining various cell types 
in undifferentiated state (Maillard et al., 2005; Ka-
ranu et al., 2000). Its ligands (Jagged-1, Delta) are 
expressed in the bone marrow milieu by osteoblasts, 
stromal cells and endothelial cells (Calvi et al., 2003). 
Forced upregulation of these molecules in feeder 
cells and HSC might further promote the expansion 
of stem cells without their differentiation (Zhang et 
al., 2003).  
Another way to go is to directly modified 
stem cells. Based on our understanding of the mo-
lecular pathways responsible for stem cells self-re-
newal and proliferation as well as discoveries of new 
genes that control stem cell proliferation and differ-
entiation, new approaches have arisen. One of them 
uses a member of the HOX gene family of transcrip-
tion factors, HOXB4. HOX genes are expressed dur-
ing early development and govern various processes 
including body-part paerning (Hombria & Love-
grove, 2003). HOXB4 has been shown to increase 
the self-renewal potential of HSC. Bone marrow of 
mice transplanted with HSC virally modified to ex-
press HOXB4 had a comparable number of HSC to 
the bone marrow of non-transplanted mice. It was 
in striking contrast to control mice that regenerated 
only 5–10% of HSC in bone marrow aer trans-
plantation (Sauvageau et al., 1995; Antonchuk et al., 
2002). Importantly, number of HSC in HOXB4 mice 
did not increase over physiological limit and home-
ostasis was maintained. The expansion of HOXB4 
positive stem cells was also observed in vitro (Sau-
vageau et al., 1995). These experiments showed that 
controlled manipulation of gene expression by stem 
cells could lead to development of new therapeutics 
strategies.
HOW TO ISOLATE STEM CELLS?
An important step in order to study the bi-
ology of stem cells is the development of suitable 
isolation methods. We have several means of isolat-
ing different cell populations including stem cells. 
Cells can be labeled with antibodies against differ-
ent cell surface markers. Antibodies can be conjugat-
ed with fluorescent dyes or magnetic particles and 
subsequently sorted using fluorescence activated 
cell sorting (FACS) or magnetic field. Specific cells 
can also be isolated according to their adherence to 
plastic and subsequently expanded in appropriate 
medium (Rando & Blau, 1994). Metabolic dyes such 
as Hoechst 33342 or Rhodamin 123 have been used 
(Goodell et al., 1996; Ratajczak et al., 1998). 
All these methods are also used to isolate 
stem cells from different tissues; unfortunately with 
only partial success. 
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The main reason why it is so difficult to pu-
rify stem cells is that they are extremely rare. The 
frequency of hematopoietic stem cells in the bone 
marrow is 1 per 104–105 bone marrow cells. The es-
timated number of heart stem cells varies in recent 
papers from 0.5% to 500–600 cells among all heart 
cells (Beltrami et al., 2003; Laugwitz et al., 2005). 
Only few tissues such as skin or gut contain higher 
number of stem cells due to their regenerative needs 
but these cells are not very well defined yet. 
The second reason why isolation of SC is so 
difficult, is that most of the stem cells lack specific 
cell surface markers. They are “lineage negative”. 
Because of this epidermal stem cells, for example, 
are isolated according to the level of expression of 
particular markers (e.g., β1 and α6 integrins) and 
not according to specific antigens expressed on 
their surface (Jones, 1996; Kaur & Li, 2000). The best 
characterized of all stem cells, HCS are isolated as 
CD34+, lin–, c-kit+, Thy-1+, CD38–, but CD34 — the 
best known HSC marker as well as c-kit and Thy-1 
are expressed not only on hematopoietic stem cells, 
but also on more mature cell populations and some 
authors showed that some HSC are CD34 negative 
(Goodell et al., 1997). 
Recently, however, new surface markers ex-
pressed by stem cells have been discovered. CXCR4, 
a receptor for α-chemokine SDF-1 (stromal derived 
factor-1) is one of them. CXCR4 is a seven trans-
membrane receptor that belongs to a large family 
of G-protein coupled receptors among which are re-
ceptors binding chemokines. It has been first shown 
to be expressed on mouse HSC (Zou et al., 1998). 
CXCR4 and SDF-1 knock-out animals had a pro-
found decrease in the number of hematopoietic stem 
cells in the bone marrow. The same animals had a 
normal number of early myeloid cells in fetal liver 
(Nagasawa et al., 1996; Zou et al., 1998). Those data 
suggested an important role of this receptor-chem-
okine axis in the homing of HSC from the fetal liver 
to the bone marrow. This was later confirmed by in 
vivo studies in NOD-SCID mice and human hemat-
opoietic cells (Peled et al., 1999; Kahn et al., 2004). 
CXCR4 is also expressed on more mature cells of the 
hematopoietic system and it is especially important 
for B-cells development (Honczarenko et al., 1999). 
CXCR4 was also shown to be expressed by 
other tissue specific stem cells. Our group showed 
that CXCR4 is expressed by skeletal muscle satellite 
cells (Ratajczak et al., 2003). The receptor is function-
al and is responsible for the migration of satellite 
cells toward an SDF-1 gradient. 
CXCR4 was also found on neuronal stem cells 
(Reiss et al., 2002). CXCR4 knock out animals exhib-
ited mild developmental defect in the central nerv-
ous system due to a migratory problem of SC. Also 
liver stem cells have been shown to express CXCR4 
and the CXCR4-SDF-1 axis seems to play a role in 
mobilization of oval cells into the site of damage af-
ter liver injury (Hatch et al., 2002).  
 Another marker first discovered in hemat-
opoietic system and subsequently found on the sur-
face of other early cells is CD133, formerly known as 
AC133 (Yin et al., 1997; Miraglia et al., 1997). It has 
five transmembrane domains and its function is not 
known yet. CD133 is present on hematopoietic stem 
cells and progenitor cell also expressing the CD34 
antigen (Yin et al., 1997; Miraglia et al., 1997). It is 
also a marker for early endothelial cell progenitors 
and very recently it has been shown to be expressed 
by neuronal stem cells (Peichev et al., 2000; Padovan 
et al., 2003).
IS “STEM CELL PLASTICITY” FOR REAL OR IT 
IS JUST A FLUKE?
The idea of stem cells plasticity arose a few 
years ago when several investigators showed that 
cells from one tissue could change their fate and 
give rise to cells of different type. It has been shown 
that cells from neuronal tissues can be transformed 
into hematopoietic cells under stress conditions 
due to myeloablation (Bjornson et al., 1999). Subse-
quently bone marrow cells were shown to transform 
into brain, muscle, liver or kidney cells. At the same 
time skeletal muscle stem cells gave rise to hemat-
opoietic cells aer transplantation in vivo (Jackson et 
al., 1999). This unexpected phenomenon was called 
transdifferentiation. It could have had a very strong 
impact on the development of new therapeutics 
strategies for untreatable diseases. Unfortunately 
several pieces of data from those early reports could 
not be reproduced in other laboratories (Kawada & 
Ogawa, 2001) or the same investigators published 
that cells they used were in fact of different origin 
(McKinney-Freeman et al., 2002), and in some in-
stances the observed transdifferentiation was an arti-
fact due to high autofluorescence of the studied cells 
(Jackson et al., 2004). Cell fusion was also stated as 
an explanation for the observed stem cell plasticity 
(Terada et al., 2002). It has been shown that under 
some circumstances cells of different lineages can 
fuse with each other and that the new cell can ac-
quire characteristics of one of them. Particularly, it 
has been noted that myeloid cells, monocytes and 
macrophages are likely to fuse with other cell types 
(Camargo et al., 2004). This would partially explain 
why HSC could so easily “transdifferentiate” into 
other cell types.
Of course we can not rule out completely the 
possibility that under special circumstances such as 
myeloablation or profound tissue damage cells could 
change their fate and transdifferentiate. But it seems 
now that this is a rather rare event with no clinical 
implications.
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NEW PLAYERS — TISSUE COMMITTED STEM 
CELLS
Cell fusion can not explain all the transdiffer-
entiation events observed by different groups. Re-
cently several papers have been published in which 
cell fusion was carefully evaluated and eventually 
ruled out (Jang et al., 2004; Wurmser et al., 2004). Our 
group proposed a different hypothesis to explain 
this phenomenon. Bone marrow cells were shown to 
be the most “plastic” cells in our body. That is why 
we became interested if maybe the bone marrow 
contains not only cells of hematopoietic and mesen-
chymal origin but also cells from other tissues. In a 
set of very carefully designed experiments we found 
that bone marrow of both humans and mice con-
tains cells with characteristics of non-bone marrow 
tissues, so called TCSC (Ratajczak et al., 2004; Kucia 
et al., 2004). In the populations of human CXCR4+ 
CD34+ CD45– cells and mouse Sca-1+ CD45– lin– cells, 
cells expressing early skeletal (Myf5, MyoD), cardiac 
(NKx2.5, GATA4), liver (CK19, α-fetoprotein) or 
neural (nestin, GAFP) markers were present at both 
mRNA and protein level (Wojakowski et al., 2004; 
Kucia et al., 2004). Aer isolation some of these cells 
could be grown in vitro toward beating cardiomyo-
cytes or neuron-like looking cells.
During injury such as heart infarct or mobi-
lization with cytokines (G-CSF) these cells are also 
mobilized into peripheral blood (Wojakowski et al., 
2004; Kucia et al., 2004). The number of TCSC is very 
low, with the highest number of these cells in young 
animals (Kucia et al., 2005), but with new advances 
in the field of stem cells expansion, they could be 
isolated from bone marrow or peripheral blood, ex-
panded in vitro and subsequently used in the clinic. 
CONCLUSION
Stem cells offer a lot of promise and expec-
tations for developing new cell-based therapeutics. 
Despite the difficulties in their isolation and in vitro 
culture, tremendous progress has been made dur-
ing the last several years. These new discoveries will 
bring stem cells closer to the patients’ beds and will 
give hope to patients suffering from untreatable dis-
eases.
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